MicroRNAs (
miRNAs or miRs) are known to play a vital role in type 2 diabetes, and
peroxisome proliferator-activated receptor-γ (PPARγ) coactivator-1α (PGC-1α) is involved in the pathogenesis of hepatic
insulin resistance. However, the correlation, if any, between PGC-1α and
miRNAs in the disease has not yet been determined. Thus, in the present study, we aimed to examine the correlation between PGC-1α and
miRNAs in diabetes. For this purpose, we used primary hepatocytes isolated from C57BL/6 mice and ob/ob mice. First, we found an inverse correlation between miR‑696 and PGC-1α
protein levels in vivo. Second, in vitro evidence demonstrated that PGC-1α expression was significantly decreased by
infection with pre-miR‑696-LV, whereas
infection with anti-miR‑696-LV increased the PGC-1α
protein levels. Third, a
luciferase reporter assay confirmed that miR‑696 directly recognizes a specific location within the 3'-untranslated region of PGC-1α transcripts. Furthermore, the biological consequences of miR‑696 targeting PGC-1α were determined by measuring the expression levels of the characteristic hepatic gluconeogenic
enzyme, PEPCK, which is regulated by PGC-1α in the liver via the coactivation of
transcription factors. Taken together, our findings demonstrate that miR‑696 plays an important role in the development of hepatic gluconeogenesis and
insulin resistance through the inhibition of PGC-1α translation in the liver.